{
    "organizations": [],
    "uuid": "fa70e25feb1ab6f6c69f895cd7580c8b92c0322c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-irom-group-unit-signs-ips-cell-tec/brief-irom-group-unit-signs-ips-cell-tech-related-license-agreement-with-q-state-biosciences-idUSL4N1P41Q8",
    "ord_in_thread": 0,
    "title": "BRIEF-I'rom Group unit signs iPS cell tech related license agreement with Q-State Biosciences",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 9 (Reuters) - I‘rom Group Co Ltd\n* Says co’s wholly owned unit ID Pharma signs iPS cell (induced pluripotent stem cell) technology related license agreement with U.S.-based firm Q-State Biosciences Inc\nSource text in Japanese: goo.gl/xfg8so\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-09T11:26:00.000+02:00",
    "crawled": "2018-01-09T16:49:38.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "rom",
        "group",
        "co",
        "ltd",
        "say",
        "co",
        "wholly",
        "owned",
        "unit",
        "id",
        "pharma",
        "sign",
        "ip",
        "cell",
        "induced",
        "pluripotent",
        "stem",
        "cell",
        "technology",
        "related",
        "license",
        "agreement",
        "firm",
        "bioscience",
        "inc",
        "source",
        "text",
        "japanese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}